Navigation Links
BioMed Central partners with AuthorMapper
Date:9/29/2009

BioMed Central, the world's largest open access publisher with over 200 peer-reviewed journals, has teamed up with AuthorMapper.com and SpringerExemplar.com to add data for its 60,000+ published articles to both platforms.

"Providing the scientific community with additional assistance in research is the goal of these services. Adding additional publisher metadata increases AuthorMapper's value and we hope to continue to incorporate content from other publishers onto these free platforms," said Dr. Olaf Ernst, Springer's President of eProducts and Innovation.

"We are very pleased that BioMed Central's articles can now be visualized using AuthorMapper," said Matthew Cockerill, Managing Director, BioMed Central. "This tool will assist researchers, funders, librarians and policymakers in identifying important scientific trends and research patterns. The inclusion of BioMed Central's articles makes it possible to demonstrate the spread of open access publishing both geographically and across disciplines. Meanwhile, SpringerExemplar.com provides an extremely useful way to see the context in which different keywords are used within the full text of BioMed Central's articles."


'/>"/>

Contact: Matt McKay
matthew.mckay@biomedcentral.com
44-020-319-22216
BioMed Central
Source:Eurekalert

Page: 1

Related biology news :

1. Duke biomedical scientists win 2 highly prized NIH Directors Awards
2. Qatar home to world-class biomedical research program
3. Virginia Tech biomedical engineering team to study knee ligament sprains
4. Boron-based compounds trick a biomedical protein
5. Marine biomedicine researchers decode structure of promising sea compound
6. NIH stimulus funding supports Emory biomedical scientists
7. Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
8. Canadian synchrotron conference sheds light on new biomedical research
9. Faculty of Translational Medicine boosts support for biomedical researchers
10. Boston University biomedical engineers teach bacteria to count
11. URI receives $18 million grant to strengthen biomedical research capacity in Rhode Island
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, the leading provider of ... that it has been named to The Silicon Review’s “20 Fastest Growing Big Data ... Cambridge Semantics serves the needs of end users facing some of the most complex ...
(Date:4/27/2016)... ... ... The Pittcon Organizing Committee is pleased to announce that Charles “Chuck” Gardner was ... since 1987. Since then, he has served in a number of key leadership positions ... the program and exposition committees. In his professional career, Dr. Gardner is the director ...
(Date:4/27/2016)... 27, 2016 NanoStruck Technologies ... NSKQB) ( Frankfurt : 8NSK) gibt ... vom 13. August 2015 die Genehmigung von der ... zusätzliche 200.000.000 Einheiten auf 400.000.000 Einheiten zu erhöhen, ... Davon wurden 157.900.000 Einheiten mit dem ersten Teil ...
(Date:4/27/2016)... ... April 27, 2016 , ... The Board ... the appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven ... the founding commercial leaders responsible for the commercialization of multiple orphan drug indications. ...
Breaking Biology Technology: